Sunovion Phoenix, AZ, USA
Jan 21, 2020
At Sunovion, patients are at the center of everything we do. We are creating innovative psychiatric, neurological and respiratory therapies that help transform people's lives, while at the same time we are playing an increasingly active role in the future of global health. Over the course of five years, Sunovion has contributed clinical advances and new treatment options, and has led advocacy and educational initiatives with cross-sector coalitions focused on the advancement of research, innovation and improvements in healthcare. Advances in research innovation, treatment access, and advocacy and community outreach have included: Pioneering a unique approach to discovery in the CNS space based on a systems neurobiology platform that facilitates rapid clinical development; Actively supporting the introduction and passage of legislation for patient protection, and championing efforts to codify the six protected classes in Medicare Part D in the U.S.; Developing and supporting leading advocacy programs, working with national advocacy partners in the U.S. including the Be Vocal: Speak Up for Mental Health, COPD Together , and Talk About It for Epilepsy! initiatives. The company has also supported hundreds of other advocacy events held regionally in the U.S., as well as in the U.K. and Canada; Hosting eight annual Hands On! days of service, involving hundreds of employees donating thousands of volunteer hours to the local communities in which Sunovion employees live and work.